China · Delayed Price · Currency is CNY R&G PharmaStudies Statistics
Total Valuation
SHE:301333 has a market cap or net worth of CNY 6.49 billion. The enterprise value is 4.77 billion.
| Market Cap | 6.49B |
| Enterprise Value | 4.77B |
Important Dates
The last earnings date was Saturday, March 28, 2026.
| Earnings Date | Mar 28, 2026 |
| Ex-Dividend Date | Jul 8, 2025 |
Share Statistics
SHE:301333 has 95.99 million shares outstanding. The number of shares has increased by 0.36% in one year.
| Current Share Class | 95.99M |
| Shares Outstanding | 95.99M |
| Shares Change (YoY) | +0.36% |
| Shares Change (QoQ) | +0.55% |
| Owned by Insiders (%) | 12.32% |
| Owned by Institutions (%) | 14.55% |
| Float | 26.69M |
Valuation Ratios
The trailing PE ratio is 47.29 and the forward PE ratio is 39.09.
| PE Ratio | 47.29 |
| Forward PE | 39.09 |
| PS Ratio | 7.63 |
| PB Ratio | 3.29 |
| P/TBV Ratio | 3.48 |
| P/FCF Ratio | 68.39 |
| P/OCF Ratio | 56.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.39, with an EV/FCF ratio of 50.25.
| EV / Earnings | 34.84 |
| EV / Sales | 5.60 |
| EV / EBITDA | 33.39 |
| EV / EBIT | 38.93 |
| EV / FCF | 50.25 |
Financial Position
The company has a current ratio of 5.60, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.60 |
| Quick Ratio | 5.44 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.19 |
| Interest Coverage | 42.77 |
Financial Efficiency
Return on equity (ROE) is 7.26% and return on invested capital (ROIC) is 47.34%.
| Return on Equity (ROE) | 7.26% |
| Return on Assets (ROA) | 3.23% |
| Return on Invested Capital (ROIC) | 47.34% |
| Return on Capital Employed (ROCE) | 6.08% |
| Weighted Average Cost of Capital (WACC) | 8.09% |
| Revenue Per Employee | 1.06M |
| Profits Per Employee | 171,124 |
| Employee Count | 2,208 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 8.94 |
Taxes
In the past 12 months, SHE:301333 has paid 16.85 million in taxes.
| Income Tax | 16.85M |
| Effective Tax Rate | 10.86% |
Stock Price Statistics
The stock price has increased by +50.31% in the last 52 weeks. The beta is 0.70, so SHE:301333's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +50.31% |
| 50-Day Moving Average | 68.53 |
| 200-Day Moving Average | 60.17 |
| Relative Strength Index (RSI) | 54.47 |
| Average Volume (20 Days) | 2,609,339 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301333 had revenue of CNY 851.01 million and earned 136.90 million in profits. Earnings per share was 1.43.
| Revenue | 851.01M |
| Gross Profit | 295.64M |
| Operating Income | 122.51M |
| Pretax Income | 155.15M |
| Net Income | 136.90M |
| EBITDA | 129.32M |
| EBIT | 122.51M |
| Earnings Per Share (EPS) | 1.43 |
Balance Sheet
The company has 1.75 billion in cash and 17.87 million in debt, with a net cash position of 1.73 billion or 18.02 per share.
| Cash & Cash Equivalents | 1.75B |
| Total Debt | 17.87M |
| Net Cash | 1.73B |
| Net Cash Per Share | 18.02 |
| Equity (Book Value) | 1.98B |
| Book Value Per Share | 20.50 |
| Working Capital | 1.77B |
Cash Flow
In the last 12 months, operating cash flow was 114.20 million and capital expenditures -19.28 million, giving a free cash flow of 94.93 million.
| Operating Cash Flow | 114.20M |
| Capital Expenditures | -19.28M |
| Depreciation & Amortization | 6.81M |
| Net Borrowing | -69.01M |
| Free Cash Flow | 94.93M |
| FCF Per Share | 0.99 |
Margins
Gross margin is 34.74%, with operating and profit margins of 14.40% and 16.09%.
| Gross Margin | 34.74% |
| Operating Margin | 14.40% |
| Pretax Margin | 18.23% |
| Profit Margin | 16.09% |
| EBITDA Margin | 15.20% |
| EBIT Margin | 14.40% |
| FCF Margin | 11.15% |
Dividends & Yields
This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 0.23%.
| Dividend Per Share | 0.16 |
| Dividend Yield | 0.23% |
| Dividend Growth (YoY) | -20.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 8.61% |
| Buyback Yield | -0.36% |
| Shareholder Yield | -0.13% |
| Earnings Yield | 2.11% |
| FCF Yield | 1.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 29, 2023. It was a forward split with a ratio of 1.6.
| Last Split Date | Jun 29, 2023 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
SHE:301333 has an Altman Z-Score of 9 and a Piotroski F-Score of 5.
| Altman Z-Score | 9 |
| Piotroski F-Score | 5 |